Transient myeloproliferative disorder (TMD), an acute leukemia-like disorder in neonates with Down's syndrome, is characterized by spontaneous regression of abnormal blast growth. Because proliferating blasts frequently express phenotypes of megakaryocytic lineage and, as a result, this disorder resembles acute megakaryoblastic leukemia (AMKL), it would be of interest to determine whether myelofibrosis, a common complication of AMKL, is also present in TMD. Pathologic observations of four autopsy cases of TMD showed that myelofibrosis was not present in any of them, whereas intralobular diffuse liver fibrosis was present in all of them.
I drome have an increased risk of leukemia,' and abnormal chromosome 21 has been suggested as playing a role in leukemogenesis.2 Interestingly, however, hematologic abnormalities indistinguishable from acute leukemia in neonates with Down's syndrome spontaneously regress in most cases. This disorder is called transient myeloproliferative disorder (TMD), transient abnormal myelopoiesis, congenital or neonatal leukemoid reaction, and so on. It has been reported that leukemia rarely develops following a remission of TMD,3-8 and the nature of abnormal proliferation of the blast cells in TMD (in other words whether it is true leukemia or non-neoplastic unstable hematopoiesis) has long been controversial. Although no definite conclusion has been drawn, recent molecular analyses of restriction fragment length polymorphism performed by two groups of Japanese investigators have disclosed a genetically monoclonal origin of the blast cells, strong evidence for a neoplastic nature.gJ0
Proliferating blast cells in TMD frequently express phenotypic markers of megakaryocytic lineage, although the phenotypes of these cells may be heterogeneous and are not necessarily restricted to this lineage.7,sJ1-14 On the other hand, a close association between Down's syndrome and acute megakaryoblastic leukemia (AMKL) has been shown by many groups of i n v e~t i g a t o r s~J~J~-~~; leukemias in patients aged 3 years or less are almost always of this subtype, although acute lymphoblastic leukemia predominates in older ~hildren.1~ Furthermore, both AMKL and TMD have been reported in patients with mosaic 21 trisomy.1s-20 Thus, TMD and AMKL are closely related disorders, and chromosome 21 is thought to play an important role in megakaryocytopoiesis, particularly in younger children.
Myelofibrosis is a well-known complication of AMKL both in children and adults and is considered one of its most characteristic f e a t u r e~.~J~,~~-~~ Because TMD is a similar, if not identical disorder, in that it involves abnormal proliferation of megakaryocytes, it would be of interest to know if myelofibrosis is a common complication in this disorder as well. We describe here the histopathologic findings of four autopsy cases and laboratory data of four nonautopsy cases of TMD. In contrast to our expectation, myelofibrosis was absent, whereas hepatic fibrosis or dysfunction was a Laboratory data of four additional cases showed hepatic dysfunction in all of them, suggesting a close association between hepatic lesions and TMD. From these results, we propose a hypothesis that the abnormal blasts with megakaryocytic properties in TMD originate from the fetal liver and cause liver fibrosis, as AMKL cells are thought to cause myelofibrosis by producing collagen-stimulating cytokines in the bone marrow. This hypothesis also seems to explain some other unique aspects of TMD. 0 1992 by The American Society of Hematology.
common complication of TMD. The pathogenesis of this liver fibrosis is discussed.
MATERIALS AND METHODS
The diagnosis of TMD was made according to the following criteria: (1) the patient has Down's syndrome, as suggested by characteristic clinical findings, including dysmorphologic facial appearance, or is confirmed by chromosome analysis to have constitutional 21 trisomy; (2) the patient has an abnormal peripheral blood picture indistinguishable from acute leukemia, which is normalized or improved during the natural course without antileukemia therapy; and (3) the patient is a neonate. Patients who died before the hematologic remission was achieved (cases 1 and 2) were included in this study because the possibility of acute leukemia was ruled out by observation of autopsy specimens.
Autopsy cases filed with the Division of Pathology of the Clinical Laboratory, National Children's Hospital from 1965 to 1990 were surveyed and 21 cases of Down's syndrome were found, four of which had TMD. Pathologic slides from postmortem specimens and clinical charts of these four cases were reviewed. Azan staining, Watanabe's silver impregnation, and Prussian blue iron staining were additionally performed on selected sections of the liver, spleen, lymph nodes, and bone marrow. The markers for each hematopoietic cell lineage of myeloid, erythroid, and megakaryocytic series were shown by immunohistochemical technique. The two-step indirect immunoperoxidase method was applied on 2 pm-thick paraffin-embedded sections of the formalin-fixed materials. Rabbit antisera against myeloperoxidase and hemoglobin were purchased from Dakopatts (Copenhagen, Denmark), and AP-2, a monoclonal antibody against platelet membrane glycoprotein (GP) IIb/IIIa complex, was kindly supplied by Dr Robert R. MontgomeryZ4 (The Blood Center of Southeastern Wisconsin, Milwaukee, WI). Horseradish-peroxidase-labeled second antibodies against rabbit or mouse Igs were purchased from Dakopatts. Endogenous peroxidase activity was blocked by immersing the sections in methanol containing 0.3% H202 for 30 minutes before incubation with the primary antibodies. Peroxidase staining was performed in neutral diaminobenzidine-H202 solution and then counterstained slightly with hematoxylin to determine cellular morphology. Control studies, in which specific antibodies were replaced by normal rabbit or mouse IgG, were always negative.
Clinical charts of four additional nonautopsy cases of TMD in patients with Down's syndrome from 1965 to 1990 were obtained from the Division of Neonatology, Department of Pediatrics, and reviewed. Laboratory data of the eight patients studied are summarized in Table 1 . Because this study includes patients examined over the past 26 years and the methods of blood chemistry analysis have changed during that period, normal ranges for each test are not identical among patients. To avoid difficulties in comparing laboratory values between patients, we standardized the data to reflect one of the normal values. The normal values obtained by the latest methods were left unchanged, serving as standards, and the older values were corrected as follows. Because normal ranges are expressed as the mean * 2 SD, differences in patients' data from corresponding original normal means were expressed as multiples of SD. Using this parameter and the standard normal values (mean and SD), patients' data were corrected by calculation. The standardized data thus obtained are shown in Table 1 with single normal ranges.
RESULTS

Report of FourAutopsy Cases
A2,600 g girl, born at 35 weeks of gestation, was observed to have hepatosplenomegaly. Her peripheral blood examination showed that her white blood cell (WBC) count was 128,0OO/)~L with 85% blasts. Blood chemistry data showed liver dysfunction ( Table 1 ). The patient died of gastrointestinal bleeding and massive intraperitoneal hemorrhage caused by gastric perforation at the age of 2 days.
A2,830 g boy, born at 38 weeks of gestation, was observed to have hepatosplenomegaly and tachypnea. His peripheral blood examination showed a high WBC count (69,0oO/pL) with 75% blasts and a low platelet count (l,OOO/p.L). Blood chemistry examination found elevated total bilirubin (12.1 mg/dL); other tests were within the normal range (Table 1 ). Hepatosplenomegaly and tachypnea progressed and the patient died of respiratory failure resulting from marked hepatosplenomeghaly at the age of 10 days.
A2,360 g boy, born at 39 weeks of gestation, was admitted to the hospital because of abdominal distention at 7 days of age. On admission, jaundice, hepatosplenomegaly, and respiratory disturbance were observed. Laboratory data showed an enormously high WBC count (289,000/ pL) with 91% blasts in circulation, and liver dysfunction (Table  1 and Fig 1) . Despite normalization of his WBC count and the disappearance of blasts from the circulation within 3 weeks, jaundice and ascites increased and hemorrhagic Case 4. A 2.200 g girl, born at 34 weeks of gestation as one of identical twins, was admitted to our hospital at the age of 13 days for evaluation of her blood, because the other twin had been found to have a leukemia-like blood picture. Her blood also had a high WBC count with blasts. At the age of 23 days, the peripheral blood contained 22% blasts and bone marrow Contained 33.2% blasts ( Table 1 and Fig  2) . At the age of 45 days, her WBC count and the number of blasts in circulation started increasing, and liver dysfunction progressed until her death. Although hematologic abnormalities had regressed and blasts had disappeared from the circulation by about 1 week before her death, hepatosplenomegaly and dyspnea became severe and she died at the age of 66 days.* 'The partner of the identical twin (case 5), a baby girl weighing 2,000 g at birth, had anal atresia and was admitted to our hospital for surgery at the age of 3 days. Her blood examination found a high WBCcount with 12% blasts, whereas bone marrow aspiration showed only I% blasts (Table I) . Although her abnormal blood picture showed improvement within 9 weeks, hepatomegaly and then splenomegaly appeared, liver dysfunction developed, and she died of dyspnea at the age of I15 days.
Pathologic Findings ut Autopsy
Diffuse intralobular liver fibrosis was observed in all four cases at autopsy. In case 1, the liver cell cords were disarranged and collagen fibers, which were increased along the vascular beds, surrounded the hepatocytes (Fig  3) . The fibrosis was diffusely and nonzonally distributed throughout the hepatic lobules. In case 4, the hepatic architecture was destroyed, and somewhat denser but very similar diffuse fibrosis was seen (Fig 4) . Although liver cell cords were highly disarranged and trapped in the fibrous tissue, the distribution of fibrosis along the vascular beds suggested a pattern of sinusoidal fibrosis. In case 3, intralobular collagenous fibrosis was dense and extensive, and disassembled hepatocytes with a pseudoductular structure were dispersed in the fibrous tissue. Here again, the distribution of fibrosis was diffuse and nonzonal (data not shown). In case 2, in which the laboratory data for liver function were normal except for elevated total bilirubin, fibrosis was the mildest among the four cases. The fibrosis was of the fine reticulin type, occupying the sinusoidal spaces and scattered diffusely (data not shown). In none of the above cases was pscudolobular nodular transformation of hepatocytes, suggesting cirrhosis, observed.
In sinusoidal spaces as well as in portal tracts in the liver, extensivc extramedullary hematopoiesis with maturing cells of all three lineages was observed in all cases (Figs 3 and 4) except ease 3. consistent with the diagnosis of TMD. The megakaryocytes, which often had atypical nuclei. In case 3, fibrosis was severe and only a very small number of hematopoietic cells were scattered in the fibrous tissue.
Intrahepatic bile stasis was present in all cases and was particularly remarkable in cases 1, 3, and 4. The stagnant bile was present mainly in the bile canaliculi or cytoplasms of hepatocytes, whereas bile ducts in the portal tracts and extrahepatic bile ducts were normal, suggesting that the For personal use only. on October 23, 2017. by guest www.bloodjournal.org From outflow of bile was blocked in the hepatic lobules or at the junction between intralobular and interlobular bile ducts. Multinucleated giant hepatocytes suggestive of neonatal hepatitis were absent. Mild to moderatc hemosiderosis was observed mainly in hepatocytes in cases 1.3, and 4, but was undetectable in case 2.
Bone marrow had normal cellularity with maturing hcmatopoietic cells of all three lineages. The ratio of erythroid to myeloid cells was dccrcased and showed a moderatc leftward shift of myeloid series in case 3, but was normal in the other cases. Monotonous blast cell growth, suggesting acute leukemia, was not present. The number of mcgakaryocytes was within the normal range, although small numbers of atypically shaped mature megakaryocytes similar to those found in the liver were also present in the marrow in some cases. In none of the patients was myelofibrosis evident.
Extramedullary hematopoiesis was present in other peripheral hematopoietic organs, including spleen, but was much milder than in the liver. Splenomegaly, which was possibly caused by both extramedullary hematopoiesis and portal hypertension attributable to hepatic fibrosis, was present in all the patients. Fibrosis was not present in the spleen or lymph nodes.
Cardiovascular anomalies, ie, atrial septal defect and patent ductus arteriosus, were found in cases 1 and 4, but not in the other cases.
Laboratory Data of Other Nonautopsy Cases
The laboratory data of the other four patients (cases 5 through 8) are included in Table 1 . Blasts in peripheral blood disappeared or were reduced in number without any antileukemia therapy. However, hepatic dysfunction was found in all of these patients, as indicated by elevated bilirubin or transaminase, although it varied from only slight to severe. Two of the patients died and, unfortunately. consent for autopsy was not obtained. The other two children were discharged after their general condition improved. No viral titers, including that for hepatitis B (Table 1) . were elevated.
DISCUSSION
TMD has the following features that are unusual for true leukemia: (1) the growth of blast cells regresses spontaneously within several weeks or months after birth without antileukemia therapy and permanent recovery is achieved, although relapse occurs on rare occasionG7; (2) the ratio of blasts in bone marrow is low compared with that in (3) extramedullary hematopoiesis, consisting of maturing cells of three lineages but not monotonous blast cell infiltration, is seen in the peripheral hematopoietic tissue^^^.^^.^; (4) the blasts have 21 trisomy with no other clonal chromosomal abnormalitiesll; and ( 5 ) mature hematopoietic colonies. which are usually completely inhibitcd in acute leukemia, are seen alongside the abnormal blast colonies in vitro! These aspects of TMD have caused controversy as to whether or not it is leukemia. However. regardless of the true nature of TMD, there is a striking common characteristic between TMD and leukemia in infants with Down's syndrome, namely, that proliferating blast cells possess the phenotypes of megakaryocytic lineage.
Myelofibrosis is a well known complication of AMKLpJ721-B Although the mechanism of myelofibrosis in AMKL is not clear, it has been suggested that cytokines, sccreted by neoplastic megakaryocytes in a qualitatively and/or quantitatively abnormal manner, cause fibrosis of the bone marrow, because megakaryocytes are known to produce the cytokines that stimulate growth and collagen synthesis of fibroblasts.21.*2.*y..U' The possible candidates for these cytokines include transforming growth factor p (TGFB),2*.31 platelet-derived growth factor (PDGF),m..UU' and platelet factor 4 (PF4)?I Among these, TGFB has been shown to be a very potent stimulator of collagen synthesis and to play the most important role in the pathogenesis of myelofibrosis.** However, despitc the similarity of TMD to AMKL, myelofibrosis was absent in our patients and those of For personal use only. on October 23, 2017. by guest www.bloodjournal.org From others,25J2,33 and to our knowledge, this complication has not been reported in TMD. Thus, myelofibrosis does not seem to be a common complication of TMD.
Instead of myelofibrosis, diffuse liver fibrosis was found in our autopsy cases, and the laboratory data of four other patients showed hepatic dysfunction in all of them. Hepatic fibrosis and/or dysfunction in TMD has been reported by other investigator^^,^^^^^,^^,^^; Nakagawa et al,32 and Becroft and Zwi33 observed an intrasinusoidal pattern of hepatic fibrosis, a finding similar to that in our present study. These results suggest a close association between TMD and hepatic lesions. It is known that jaundice and hepatic abnormalities are more common in children with Down's ~y n d r o m e .~~,~~ However, relatively few detailed studies on histopathologic changes of the liver in patients with Down's syndrome have been published. Seeff et aP6 studied 48 patients with Down's syndrome and found that 42 had liver fibrosis, including 14 cases of cirrhosis. However, most of their cases were adults and older children, in whom the situation is different from that of neonates because institutionalized older patients with Down's syndrome are known to be at higher risk for viral hepatitis than others3' Rosner and Lee38 surveyed 276 cases of Down's syndrome accompanying leukemia or TMD in the literature, in which 4 of 22 patients with TMD had jaundice and/or cirrhosis. However, the etiology and histology of the hepatic lesions are unfortunately not clear from the literature.
Our cases may fall clinically into the category of so-called neonatal hepatitis syndrome (or "giant cell hepatitis"), a hepatocyte disorder of unknown etiology. Although hepatic diffuse fibrosis and excessive hematopoiesis may be seen in this disorder, the lack of multinucleated giant hepatocytes in our patients does not fit with this diagnosis. Viral hepatitis caused by intrauterine infection is also an unlikely cause of hepatic fibrosis in our patients because none of the virus titers studied were elevated, and the uniform nonzonal distribution of fibrosis along the vascular beds was unlike the portal fibrosis seen in viral hepatitis. Thus, the liver fibrosis in TMD is histologically unusual and does not seem to be attributable to any of the known causes of hepatic fibrosis, including bile duct atresia, intrahepatic familial cholestatic syndromes, al-antitrypsin deficiency, metabolic disorders, or hemosiderosis. We therefore consider that the hepatic fibrosis accompanying TMD results from certain highly unusual conditions. The extent of hepatic fibrosis was not necessarily proportional to the age of each patient in this study; one patient only 2 days old (case 1) had extensive fibrosis, indicating that the fibrosis occurred during the fetal period. Besides TMD, hepatic fibrosis has been reported by other investigators in cases of primary m y e l o f i b r o~i s~~?~ and osteopetrosis,4l both of which had sinusoidal fibrosis and extramedullary hematopoiesis in the liver, and in a patient with AMKL with hepatic A possibility has been suggested that the fibrosis is caused by cytokines elaborated by megakaryocytes in the liver.33, 39, 40, 42 This mechanism seems to explain why liver fibrosis, but not myelofibrosis, was present in TMD, although abnormal megakaryoblastic proliferation similar to AMKL occurs in this disorder. On the basis of the above observations, we propose the following hypothesis as a mechanism of the liver fibrosis: the abnormal blasts in TMD proliferate in the liver during the fetal period, and the cytokines, including TGFP, PDGF, and PF4, which are stimulators of growth and collagen synthesis in fibroblasts, produced by these cells with megakaryocytic properties may cause fibrosis of the liver in a similar fashion to the myelofibrosis in AMKL, in which leukemia cells grow in the bone marrow.
Some other unique aspects of TMD also seem relevant to fetal hematopoiesis. An outstanding feature of TMD is its spontaneous remission. If the abnormal blasts in TMD are of fetal liver origin, a transition in the site of hematopoiesis from the liver to the bone marrow after birth could influence the proliferation of these cells and might cause their regression. The facts that the ratio of blasts in marrow is low compared with that in peripheral blood25,26 and that normal hematopoietic colony-forming cells in the bone marrow, unlike the case of acute leukemia, are not completely suppressed in TMD,8 support our hypothesis that the major organ of abnormal cell origin is the liver and that the bone marrow is only involved by these cells.
In conclusion, we found that unusual hepatic fibrosis, histologically distinct from that caused by already known diseases, was closely associated with TMD and we proposed a hypothesis regarding the pathogenesis of this fibrosis. Although this hypothesis is based on only the results of histopathologic observations, it will be of value to test the hypothesis from various points of view because it seems to explain some specific cellular biologic aspects of TMD.
